(“4babsebio” or the "Company")
Exercise of Options
Admission to AIM
Application will be made for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective at
Total Voting Rights
Following Admission, the total number of ordinary shares in issue will be 12,805,208. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares with voting rights will be 12,805,208. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as amended by regulation 11 of the market abuse (amendment) (EU Exit) regulations 2019/310.
For further enquiries, please contact:
4basebio PLC +44 (0)12 2396 7943Heikki Lanckriet , CEOCairn Financial Advisers LLP (Nominated Adviser) +44 (0)20 7213 0880Jo Turner /Sandy Jamieson Cavendish Capital Markets Limited (Broker) +44 (0)20 7220 0500Geoff Nash /Charlie Beeson